PCV107 PREFERENCE AND WILLINGNESS-TO-PAY FOR NOVEL ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION â€“ PRELIMINARY RESULTS FROM A TWO-CENTRE SURVEY IN CHINA

Preliminary Results

Willingness to Pay for Novel Oral Anticoagulants in Non-Valvular Atrial Fibrillation and Deep Vein Thrombosis Patients

International Journal of Cardiology ◽

10.1016/j.ijcard.2017.09.148 ◽

2017 ◽

Vol 249 ◽

pp. S42-S43

Author(s):

K.T. Lau ◽

T.E. Poh

Keyword(s):

Atrial Fibrillation ◽

Deep Vein Thrombosis ◽

Willingness To Pay ◽

Oral Anticoagulants ◽

Vein Thrombosis ◽

Deep Vein

Faculty Opinions recommendation of Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717962318.793465537 ◽

2012 ◽

Author(s):

Jack Kron ◽

Eric Stecker

Keyword(s):

Atrial Fibrillation ◽

Systematic Review ◽

Meta Analysis ◽

Oral Anticoagulants ◽

The Novel ◽

Efficacy And Safety

Novel oral anticoagulants for stroke prevention in atrial fibrillation: a focus on the older patient

International Journal of General Medicine ◽

10.2147/ijgm.s39379 ◽

2013 ◽

pp. 167 ◽

Cited By ~ 12

Author(s):

S.w. Yates

Keyword(s):

Atrial Fibrillation ◽

Stroke Prevention ◽

Oral Anticoagulants ◽

Older Patient

Psychological effects of treatment with novel oral anticoagulants in non-valvular atrial fibrillation patients

The Anatolian Journal of Cardiology ◽

10.14744/anatoljcardiol.2016.7030 ◽

2016 ◽

Author(s):

Can Ramazan Oncel

Keyword(s):

Atrial Fibrillation ◽

Oral Anticoagulants ◽

Psychological Effects ◽

Warfarin or novel oral anticoagulants for atrial fibrillation?

The Lancet ◽

10.1016/s0140-6736(13)62376-4 ◽

2014 ◽

Vol 383 (9921) ◽

pp. 931-933 ◽

Cited By ~ 15

Author(s):

Torben Bjerregaard Larsen ◽

Gregory Y H Lip

Keyword(s):

Atrial Fibrillation ◽

Oral Anticoagulants ◽

Risk of intracranial haemorrhage in patients with atrial fibrillation treated with novel oral anticoagulants: testing the equivalence margins between dabigratran, rivaroxaban and apixaban

European Journal of Clinical Pharmacology ◽

10.1007/s00228-014-1644-7 ◽

2014 ◽

Vol 70 (4) ◽

pp. 505-506 ◽

Cited By ~ 4

Author(s):

Andrea Messori ◽

Dario Maratea ◽

Valeria Fadda ◽

Sabrina Trippoli

Keyword(s):

Atrial Fibrillation ◽

Intracranial Haemorrhage ◽

Oral Anticoagulants ◽

Comparison of the Phase III Clinical Trial Designs of Novel Oral Anticoagulants Versus Warfarin for the Treatment of Nonvalvular Atrial Fibrillation: Implications for Clinical Practice

American Journal of Cardiovascular Drugs ◽

10.1007/s40256-013-0062-z ◽

2014 ◽

Vol 14 (2) ◽

pp. 111-127 ◽

Cited By ~ 16

Author(s):

Carlos J. Gonzalez-Quesada ◽

Robert P. Giugliano

Keyword(s):

Atrial Fibrillation ◽

Clinical Trial ◽

Clinical Practice ◽

Oral Anticoagulants ◽

Phase Iii ◽

Nonvalvular Atrial Fibrillation ◽

Phase Iii Clinical Trial ◽

Clinical Trial Designs

P830Which factors recorded during routine care predict treatment discontinuation of novel oral anticoagulants in patients with non-valvular atrial fibrillation?

EP Europace ◽

10.1093/ehjci/eux151.012 ◽

2017 ◽

Vol 19 (suppl_3) ◽

pp. iii151-iii151

Author(s):

M. Johnson ◽

C. Lefevre ◽

D. Evans ◽

L. Lacoin ◽

E. Ridha ◽

...

Keyword(s):

Atrial Fibrillation ◽

Oral Anticoagulants ◽

Routine Care ◽

Treatment Discontinuation ◽

Efficacy and Limitations of Warfarin and Novel Oral Anticoagulants with Atrial Fibrillation

Contemporary Cardiology - Left Atrial Appendage Closure ◽

10.1007/978-3-319-16280-5_2 ◽

2016 ◽

pp. 17-36

Author(s):

John A. Cairns

Keyword(s):

Atrial Fibrillation ◽

Oral Anticoagulants ◽

The Use of Novel Oral Anticoagulants in Atrial Fibrillation

Cardiovascular & Haematological Disorders - Drug Targets ◽

10.2174/1871529x1502151209111019 ◽

2015 ◽

Vol 15 (2) ◽

pp. 97-100 ◽

Cited By ~ 1

Author(s):

Uzair Ansari ◽

Michael Behnes ◽

Christian Fastner ◽

Ibrahim Akin

Keyword(s):

Atrial Fibrillation ◽

Oral Anticoagulants ◽